Empowering research teams with immediate access to high-quality immune cells. Supporting oncology, immunology, and vaccine development through RUO-grade white blood cells — delivered fast.
Founded in 2025, Alluxion Bio was created with a bold vision: to streamline discovery in life sciences by delivering high-quality, ready-to-use immune cells to research teams when and where they need them.
Our mission is to remove barriers in biomedical R&D by offering fast, reliable access to white blood cells that support preclinical workflows in oncology, immunology, and vaccine development. We believe acceleration in science starts with access — and that starts with us.
With a team of specialists in immunology, cell biology, and translational research, we bring deep technical experience and a strong commitment to helping researchers reach meaningful breakthroughs. We collaborate with labs, startups, and institutions worldwide to power innovation with practical, scalable support.
Whether you're running a single experiment or scaling a pipeline, Alluxion Bio is your trusted partner for ethical sourcing, rapid delivery, and expert assistance.